Sam Kintz is the founder of Enliven Therapeutics. Enliven Therapeutics has raised $230M in total funding. Latest round: Growth.
Sam Kintz is the Co-Founder and Head of Pipeline at Enliven Therapeutics, a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. He previously served as the company's CEO and was instrumental in the early development of ELVN-001 and advancing it into clinical trials.
Full founder directory · Investor directory · Company funding database · Fundraising library